Hannah Kim,Nilay Joshi,Sara Naqvi et al.
Hannah Kim et al.
Health literacy and control of inflammatory activity in patients with recent-onset rheumatoid arthritis [0.03%]
Javier Bachiller-Corral,María Auxiliadora Martin-Martínez,Diana Botello-Corzo et al.
Javier Bachiller-Corral et al.
Objective: To determine the association between health literacy (HL) and disease activity in patients with recent-onset rheumatoid arthritis. Methods: ...
Management of interstitial lung disease in systemic autoimmune rheumatic diseases: a survey of rheumatologists and pulmonologists [0.03%]
Genna Braverman,Kerri I Aronson,Charlene Thomas et al.
Genna Braverman et al.
Objectives: To determine whether rheumatologists and pulmonologists have distinct disciplinary approaches to the management of systemic autoimmune rheumatic disease (SARD)-interstitial lung disease (ILD). ...
The prevalence of pulmonary airway lesions is high in HTLV-1-positive rheumatoid arthritis: a cross-sectional observational study [0.03%]
Chihiro Iwao,Kunihiko Umekita,Masatoshi Kimura et al.
Chihiro Iwao et al.
Objective: To investigate whether human T cell leukaemia virus type 1 (HTLV-1) infection increases the risk of respiratory complications in patients with RA, focusing on high-resolution computed tomography (HRCT) findings...
Marie Vermant,Thomas Pauwels,Tine Follet et al.
Marie Vermant et al.
Objectives: Interstitial lung disease (ILD) is an important comorbidity in RA. Its true prevalence remains unclear. We assessed reported prevalences across different diagnostic approaches. ...
Decision on Optimal Combinatorial Therapies in Immune-mediated inflammatory diseases using Systems approaches (DocTIS): protocol for a single-arm, adaptive basket trial in rheumatoid and psoriatic arthritis [0.03%]
Rory Sheppard,Myrsini Gianatsi,Ian Thomas et al.
Rory Sheppard et al.
Objectives: Current treatments for rheumatoid arthritis (RA) and psoriatic arthritis (PsA) reduce disease activity but often fail to achieve sustained remission. The Decision on Optimal Combinatorial Therapies in Immune-m...
Janus kinase inhibitor and rituximab in rheumatoid arthritis: is it a safe combination? [0.03%]
janus激酶抑制剂与利妥昔单抗联合治疗类风湿性关节炎安全吗？
Hadi Rabee,Arti Mahto
Hadi Rabee
Screening failure in systemic sclerosis randomized trials: reporting, rates, causes and trends over time [0.03%]
系统性硬化症随机试验的筛选失败：报告、发生率、原因及随时间变化的趋势
Delphine Sophie Courvoisier,Barbara Russo,Iulia-Simona Chirică et al.
Delphine Sophie Courvoisier et al.
Objectives: To evaluate the completeness of reporting of pre-randomization patient' flow in SSc randomized controlled trials (RCTs) and to estimate the extent and reasons for screening failure. ...
EBV-positive diffuse large B-cell lymphoma with central nervous system involvement in Anti-Mi-2-positive dermatomyositis [0.03%]
抗Mi-2阳性皮肌炎伴EB病毒阳性的弥漫性大B细胞淋巴瘤及中枢神经系统受累
Shion Kachi,Ran Nakashima,Hiroaki Ito et al.
Shion Kachi et al.
Pulmonary cystic destruction in systemic sclerosis and antisynthetase syndrome associated non-specific interstitial pneumonitis: a case series of a novel radiological phenotype [0.03%]
系统性硬化症和抗合成酶综合征相关非特异性间质性肺炎的肺囊性破坏：一种新型放射学表型的病例系列研究
Matthew Wells,Giles Dixon,Nidhi Bhatt et al.
Matthew Wells et al.
Objectives: To describe a novel radiographic phenotype of systemic autoimmune rheumatic disease-associated interstitial lung disease (SARD-ILD) observed within a regional specialist multidisciplinary (MDT) service. ...